CIK: 1236922 - Address: C/o Urovant Sciences, Inc., 5281 California Ave., Suite 100, Irvine, CA 92617
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111183719630034
P%wins100100100100100
S%ret116-1-3-1-8-12-16-7
S%wins83833383838375

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/20/17 16:35
1/18/17
VRAYViewray, Inc.DEHealthElcMdElectromedical & ElectrotheraBansal AjayOHOCFOP.d1983.1706383470D-1213142132453818371963
3/13/06 14:35
3/10/06
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsBansal AjayCAHFormer CS-10319.9233-5-505-2-41-1-20-44
9/7/05 19:01
9/7/05
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsBansal AjayCAOCFO,VP FM.d165.431830D532420-1-8-1610-5-16-147-16
9/7/05 19:01
9/7/05
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsBansal AjayCAOCFO,VP FS.d-6019.9618-3-1000D532420-1-8-1610-5-16-147-16
5/17/05 14:15
5/17/05
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsBansal AjayCAOCFO,VP FS.d-6816.4113-4-1000D109-36-71813146-1266-420
1/5/05 13:32
1/3/05
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsBansal AjayCAOCFO,VP FM.d385.431373925D1123412731-1-3-6-2-1-6-25-11-13
1/5/05 13:32
1/3/05
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsBansal AjayCAOCFO,VP FS.d-14020.0613-7-2225D1123412731-1-3-6-2-1-6-25-11-13
12/1/04 15:05
12/1/04
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsBansal AjayCAOCFO,VP FM.d85.43152625D11140-134731191827409-6-3-10
12/1/04 15:05
12/1/04
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsBansal AjayCAOCFO,VP FS.d-3020.0015-2-625D11140-134731191827409-6-3-10
3/8/04 21:37
3/4/04
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsBansal AjayCAOCFO,VP FM.d155.062631425D953891067335272622-6-73-7-39-31
3/8/04 21:37
3/4/04
NKTRNektar TherapeuticsDEHealthDrugPharmaceutical PreparationsBansal AjayCAOCFO,VP FS.d-6621.9126-3-1125D953891067335272622-6-73-7-39-31

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact